ZoomMed Enters Into a Major Strategic Alliance With a Healthcare Service Provider to Penetrate the US Market
26 Julio 2011 - 8:34AM
Marketwired
ZoomMed inc. (TSX VENTURE: ZMD) is thrilled to announce that its
wholly owned subsidiary, ZoomMed USA, has entered into a major
strategic alliance agreement with a Healthcare service provider, an
industry leading web based healthcare provider which offers a
comprehensive connectivity solution to approximately 30,000
american physicians.
Compared to the Canadian market, 30,000 physicians represent the
equivalent of all active physicians in Quebec and Ontario combined,
and 60% of all canadian physicians.
The agreement provides that ZoomMed's own web-based
e-Prescribing platform "ZRx Prescriber" will be interfaced with
this new partner solutions and will be positioned on its portal as
their exclusive e-Prescribing solution to the physicians visiting
or using the portal.
By interfacing their respective solutions, the Healthcare
provider will complement its state of the art portfolio of
solutions offered to its clients and ZoomMed will gain a
technologically simple and privileged access to an impressive
network of physicians and institutions. This being so, each party
will gain in consolidating and expanding their market as each of
them will continue exploiting independently their respective
business model within this market. Statistically, only 25% of
American physicians use technology such as e-Prescribing solutions,
so the market opportunities are huge for both the healthcare
provider and ZoomMed
Yves Marmet, President and CEO of ZoomMed inc. commented: " I am
particularly proud of this major strategic alliance, which will
facilitate and definitely confirm the introduction of our ZRx
Prescriber into the huge American physician's community by
providing them with instant access to our application on a portal
accessed by over 30,000 MDs. Physicians have the utmost respect and
confidence in this healthcare provider and its mission to provide "
Better healthcare through better communications ". They know that
if this healthcare provider has selected the ZRx Prescriber as
their preferred and exclusive e-Prescribing solution, it has to be
a testimony to the quality of our web based solution. "
For ZoomMed, its business model will continue to leverage the
strategic value of the ZRx Prescriber's user community for a series
of potential partners and sponsors, such as pharmaceutical
companies and others, wishing to offer their services, content or
information to this community. Thus, in the U.S.A. the value of
this strategic positioning is huge. Accordingly, ZoomMed's 2011
action plan will continue to be, as previously stated: "putting as
many of its ZRx Prescribers in the hands of American doctors and
this as soon as possible".
About ZoomMed
ZoomMed's developed the ZRx Prescriber, a technological
innovative Web application that enables physicians to use a
wireless device, such as the IPod Touch™, IPhone™, IPad™, Google
Android™, other PDA's or computers, to write and rapidly deliver
scripts. The ZRx Prescriber is quick, efficient and intuitive.
Since it is a stand-alone product, it can easily be integrated to
any Electronic Medical Record application (EMR). Furthermore,
ZoomMed also offers "PraxisLab" a new application that enhances all
aspects of the prescription filling process and the complete
pharmacists patient file management. PraxisLab uses
state-of-the-art protocols and up-to-date software standards,
allowing high compatibility with existing software, as well as new
generation software.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Contacts: ZoomMed Mr. Yves Marmet President and Chief Executive
Officer (450) 678-5457, Ext 228 info@zoommed.com
www.zoommed.com
Zoommed (TSXV:ZMD)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Zoommed (TSXV:ZMD)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024